Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT07497776
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- National Institute of Kidney Disease and Urology (NIKDU)
- Registry
-
NCT07497776
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Bangladesh
- Registry status
- Completed
Technical summary
Registry record NCT07497776. Non-randomized; no masking; primary purpose supportive care. Start 2024-01-27 (actual); primary completion 2025-08-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome
- Condition
- Dyslipidaemia
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- National Institute of Kidney Disease and Urology (NIKDU)
Record details
- Record id
cardio:ct-nct07497776- Content hash
ed9ca9844622d8c8b929402ae07ae5d5f795792649fd973aecb2209c69f26af5